Genius IWRS™

Treatment Allocation

Genius IWRS™

Treatment Allocation

Randomization is fundamental to clinical trials—It prevents the selection bias and insures against the accidental bias. It produces the comparable groups and eliminates the source of bias in treatment assignments.

Genius IWRS™ is a web-based application, seamlessly integrated with Genius EDC and Genius DSM™, reducing the need or completely eliminating traditional telephone-based randomization systems. Our expert biostatisticians and IWRS programmers provide fixed, dynamic, multi-stage and adaptive randomization methods.

Genius IWRS™ provides

  • Complete Subject Enrollment Tracking (screening through end of study)
  • Real-time team notifications
  • Eligibility and screening visit enforcement
  • Subject Randomization
  • Block-based or centrally managed with multiple stratifications
  • Study’s custom randomization algorithm
  • Global access by authorized clinical site personnel 24/7
  • Emergency/Pharmacovigilance code breaks
  • Connection with external tools (DSM, eCRF, CTMS)
  • 21 CFR Part 11 Compliance
Share This

Exom is now Kapadi

 

Once three entities – OncoBay Clinical, Clinscience, and Exom Group s.r.l – now we stand as one, bringing forth a symphony of expertise and seamless operations. To celebrate our unity, we re-brand under the banner of Kapadi, and embark on a new chapter of exceptional service in oncology clinical research.

Kapadi is not just a name; it's a testament to our fusion. It signifies the our standing as a global CRO powerhouse committed to accelerating groundbreaking cancer therapies that uplift patients worldwide. From conceptualizing studies, navigating regulations, and analyzing data, we provide a comprehensive array of services designed to empower your oncology clinical trials.

Visit Kapadi.com